A Phase I dose escalation and cohort expansion study of ERY974
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Chugai Pharmaceutical Company, Ltd.
Start Date
November 30, 2016
End Date
August 27, 2020
Administered By
Duke Cancer Institute
Awarded By
Chugai Pharmaceutical Company, Ltd.
Start Date
November 30, 2016
End Date
August 27, 2020